Parallax Volatility Advisers
PRCT icon

Parallax Volatility Advisers’s Procept Biorobotics PRCT Stock Holding History

Parallax Volatility Advisers’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,400
Closed -$368K – 2539
2023
Q2 		$368K Sell
10,400
-164,600
-94% -$5.44M ﹤0.01% 1748
2023
Q1 		$4.97M Buy
+175,000
New +$6.17M 0.01% 864

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's PRCT Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Procept Biorobotics (PRCT) in Q2 2023, closing a stake of 18,098 shares — an estimated $598K sold.

Parallax Volatility Advisers first reported a position in PRCT in Q1 2023 and held it in 1 quarter. The position peaked at $514K in Q1 2023. 120 funds tracked by Wall St. Rank hold PRCT as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Procept Biorobotics position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 18,098 Procept Biorobotics shares in Q2 2023, an estimated $598K.
  • Parallax Volatility Advisers first reported a position in Procept Biorobotics in Q1 2023 and held it in 1 quarter.
  • Parallax Volatility Advisers's Procept Biorobotics position peaked at $514K in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.